Suchen und Finden
Service
Textbook of Small Animal Emergency Medicine
Kenneth J. Drobatz, Kate Hopper, Elizabeth A. Rozanski, Deborah C. Silverstein
Verlag Wiley-Blackwell, 2018
ISBN 9781119028949 , 1536 Seiten
Format PDF, OL
Kopierschutz DRM
Textbook of Small Animal Emergency Medicine
3
Contents
7
Contributors
15
Dedication
30
Preface
31
About the Companion Website
32
Section 1 Emergency Medicine Overview
33
1 Goals in Veterinary Emergency Medicine
35
The 40-Year Evolution of Goals in Veterinary Emergency Medicine
35
The Patient
35
The Client and the Team
35
Principles of Primary Survey, Resuscitation, Secondary Survey and Definitive or Refined Diagnostics and Treatment of Veterinary Emergency Patients
36
References
37
2 Triage
38
Introduction
38
Telephone Triage
38
First Aid and Transport
38
Waiting Room Triage
39
Investigation and Stabilization of the Patient
40
History
40
Emergency Physical Examination
41
Emergency Stabilization
42
References
42
Section 2 Common Conditions in Emergency Medicine
43
3 Neurological Disorders
45
Initial Management of the Acute Neurological Patient
45
Neuroanatomic Localization
45
Initial Assessment
45
Consciousness
45
Posture and Body Position
46
Abnormal Movements
46
Ambulation and Gait
46
Cranial Nerves
47
Neurolocalization
47
Approach to Differential Diagnoses
47
References
49
4 Respiratory Distress
50
Introduction
50
Does Oxygen Help?
50
Signalment
51
Any Relevant Past Medical History? What Has Happened Today?
51
Is There Hyperthermia or Hypothermia?
51
Is There Loud Breathing?
51
Is There Any Cough or Wheeze?
52
Are There Extra Lung Sounds?
52
What Does Point-of-Care Ultrasound Show You?
53
What Should I Tell the Owner?
53
References
53
5 Ventricular Ectopy
54
Introduction
54
Presentation
54
Diagnosis
54
Causes
54
Non-Cardiac Causes
54
Cardiac Causes
55
Treatment
55
Class I Antiarrhythmics
55
Class II Antiarrhythmics
56
Class III Antiarrhythmics
56
Other Antiarrhythmics
57
Defibrillation
57
6 Acute Abdomen
58
History and Physical Examination
58
Clinical Pathology
58
Abdominal Imaging
58
Collection of Peritoneal Effusion
59
Analysis of Peritoneal Effusion
60
Abdominal Surgery
61
Nutritional Support
61
Conclusion
61
References
61
7 The Collapsed Patient
63
Introduction
63
Pathophysiology of Syncope
63
Causes of Syncope
64
Cardiac Syncope
64
Reflex-Mediated Syncope
65
Collapse or Syncope-Like Conditions
66
Patient Evaluation and Risk Stratification
67
Blood Pressure
67
ECG
67
Long-Term Monitoring
67
Bloodwork
67
Treatment
68
References
69
8 Global Approach to the Trauma Patient
71
Introduction
71
Pathophysiology
71
Triage Evaluation and Intervention
72
Further Evaluation
73
Diagnostic Imaging
74
Conclusion
75
References
75
9 Reproductive Emergencies
76
Introduction
76
Female Reproductive Emergencies
76
Vaginal Discharge
76
Swollen Vulva or Mass Lesion
77
Reproductive Emergencies of the Pregnant Patient
77
Reproductive Emergencies of the Periparturient Patient
77
Male Reproductive Emergencies
78
Paraphimosis and Priapism
78
Prostate Disorders
78
Testicular Torsion
78
References
79
10 Anemia
80
Introduction
80
Etiology
80
Consequences of Anemia
80
Clinical Signs
82
Diagnosis
82
History
82
Physical Examination
82
Laboratory Assessment
82
Diagnostic Approach
84
Decreased Erythropoiesis
84
Hemorrhagic Anemia
85
Hemolytic Anemia
85
References
85
11 Jaundice
87
Definition
87
Physiology
87
Pathophysiology
87
Evaluation of the Icteric Patient
88
Physical Examination
88
Diagnostic Evaluation
90
Treatment
91
References
91
12 Ophthalmic Emergencies
92
Proptosis
92
Eyelid Lacerations
92
Corneal Lacerations
92
Deep Corneal Ulcers
94
Primary Glaucoma
95
Acute Anterior Uveitis
95
Anterior Lens Luxation
95
Acute Blindness
96
References
97
13 Vomiting, Regurgitation, and Diarrhea
98
Differentiation Between Vomiting and Regurgitation
98
Vomiting
98
Physiology of Vomiting
98
Differential Diagnoses
98
Clinical Approach
98
General Treatment Guidelines
99
Regurgitation
99
Differential Diagnoses
99
Clinical Approach
100
General Treatment Guidelines
100
Prognosis
101
Diarrhea
101
Gastrointestinal Causes
101
Extragastrointestinal Causes
101
Clinical Approach
101
Treatment
102
References
102
14 Dysuria
104
Introduction
104
Alteration in Volume or Frequency of Urination
104
Dysuria
104
Stranguria
104
Pollakiuria
104
Decreased Size of Urine Stream
105
Reflex Dyssynergia
105
Urinary Obstruction
105
Periuria
105
Incontinence
105
Polyuria/Polydipsia
105
Alteration in Urine Consistency
105
Discolored Urine
105
Malodorous Urine
105
Crystalluria or Small Uroliths in Urine
105
Other Clinical Findings That May Be Associated With Lower Urinary Tract Disease
106
Abdominal Fluid
106
Excessive Licking of Prepuce or Vulva
106
Blood Dripping from Prepuce or Vulva
106
Prostatomegaly
106
Purulent Discharge from Prepuce or Vulva
106
Painful Rectal Examination
106
Painful Defecation
106
Painful or Abnormal Gait of Rear Limbs
106
Fever
106
Physical Examination Findings in Patients with Lower Urinary Tract Signs
106
Additional Analytical Procedures in Patients with Dysuria
107
Management of Patients with Dysuria
107
References
107
15 Dermatological and Ear Disease
108
Dermatological Emergencies
108
Pyotraumatic Dermatitis
108
Pyoderma
109
Otitis Externa
112
Ectoparasites
116
Atopy
118
Conclusion
120
References
120
16 Toxin Exposure
124
Introduction
124
References
128
17 Epistaxis
129
Introduction
129
Pathophysiology
130
Further Laboratory Evaluation
130
Nasal Imaging
130
Nasal Biopsy
130
Emergency Management
131
Conclusion
131
References
132
18 Fever
133
Physiology of Normal Thermoregulation
133
What is Fever?
133
Is Fever Helpful or Harmful?
133
How to Differentiate Fever from Hyperthermia
134
History
134
Clinical Signs
134
Primary Differentials for Cause of Fever
134
Early Diagnostics to Consider for Febrile Patients
135
Treatments to Consider
136
References
137
Section 3 Emergency Conditions by System
139
A. Neurological Disorders
141
19 Traumatic Brain Injury
143
Introduction
143
Pathophysiology
143
Physical Examination
144
Systemic Assessment
144
Neurological Assessment
144
Diagnostic Imaging
144
Treatment
145
Initial Stabilization
145
Treatment Strategies Specific for TBI
145
Prognosis
147
References
147
20 Altered Mentation
150
Introduction
150
Initial Assessment (see Chapter 2)
150
Neuroanatomy
150
Neurological Examination
150
Mental Status and Neurological States of Consciousness
150
Neuro-ophthalmological Signs
151
Postural Response
151
Respiratory Patterns
152
Differential Diagnoses and Diagnostic Approach
152
Diagnostic Approach
152
Laboratory Testing
152
Advanced Neurological Testing
152
Treatment and Monitoring
153
Conclusion
154
References
154
21 Seizures
156
Introduction
156
History
156
Initial Patient Assessment (see Chapter 2)
156
Neurological Examination
157
Differential Diagnoses
157
Quick Assessment Tests
158
Extended Laboratory Tests and Diagnostic Images
158
Emergency Management
158
Benzodiazepines
159
Phenobarbital
159
Levetiracetam
159
Propofol
159
Ketamine
160
Dexmedetomidine
160
Acepromazine
160
Intracranial Pressure
160
Long-term Management of Seizures
161
References
162
22 Intracranial Disease
163
Clinical Signs
163
Diagnostic Tests
163
Differential Diagnoses and Prognosis
164
Neoplasia
164
Immune Mediated
164
Infectious
165
Vascular
165
Metabolic
166
Congenital Malformation
166
Trauma
167
References
167
23 Vestibular Disease
169
Introduction
169
Clinical Signs (Table 23.1)
169
Peripheral Vestibular Disease
169
Central Vestibular Disease
170
Paradoxical Vestibular Disease
170
Bilateral Peripheral Vestibular Disease
171
Common Causes of Vestibular Disease (Table 23.2)
171
Peripheral Vestibular Disease
171
Central Vestibular Disease
172
Diagnostics
174
References
175
24 Spinal Trauma
178
Causes
178
Pathophysiology
178
Initial Approach
178
Neurological Assessment
180
Localizing spinal cord lesions
180
Severity and Prognostication
180
Diagnosis
181
Radiography
181
Myelography
181
Computed Tomography
181
Magnetic Resonance Imaging
182
Treatment of Spinal Cord Injury
182
Management of Secondary Spinal Cord Injury
182
Management of Primary Spinal Cord Injury
182
Nursing, Rehabilitation, and Ongoing Care
183
References
183
25 Intervertebral Disk Disease
186
Introduction
186
Applied Anatomy
186
Pathogenesis
186
Disk Protrusion and Extrusion
187
Clinical Signs
187
Diagnostics
189
Treatment
189
Medical Management
189
Surgical Management of IVDH
190
References
191
26 Diskospondylitis
193
Introduction
193
Pathophysiology
193
Causative Agents
193
Signalment
194
Clinical Signs
194
Diagnosis
194
Radiography
194
Cross-Sectional Imaging
195
Laboratory Tests
195
Treatment
196
Prognosis
196
Complications
197
References
197
27 Lower Motor Neuron Disease
198
Introduction
198
Clinical Signs
198
Diagnosis and Initial Approach
198
Causes of Generalized Lower Motor Neuron Paresis
202
Acute Polyradiculoneuritis
202
Tick Paralysis
203
Botulism
204
Fulminant Myasthenia Gravis
204
Other Causes
205
References
206
B. Respiratory Disease
209
28 Brachycephalic Syndrome
211
Introduction
211
Systemic Consequences of the Brachycephalic Obstructive Airway Syndrome
211
Acute Upper Airway Obstruction: Current Concepts
212
Treatment of Brachycephalic Syndrome
215
Future Directions
216
References
216
29 Feline Upper Respiratory Complex
218
Introduction
218
Causes/Infectious Agents
218
Feline Herpesvirus-1
218
Feline Calicivirus
218
Clinical Presentation
219
Feline Herpesvirus-1
219
Feline Calicivirus
219
Risk Factors
220
Diagnosis
220
Treatment (Table 29.2)
220
Supportive Treatment
220
Antibiotics
220
Antivirals
222
Prevention
222
Prognosis
222
References
223
30 Laryngeal Paralysis
225
Introduction
225
Clinical Signs
225
Emergency Treatment
225
Emergency Diagnostic Tests
226
Long-Term Management
227
Prognosis
227
References
227
31 Tracheobronchial Injury and Collapse
228
Anatomy and Physiology of the Trachea
228
Emergency Management
228
Tracheobronchial Injury
229
Clinical Signs and Physical Examination Findings
229
Diagnostic Testing
230
Treatment of Tracheobronchial Injuries
231
Tracheal and Bronchial Collapse
232
Clinical Signs and Physical Examination Findings
232
Diagnostic Testing
233
Treatment of Tracheobronchial Collapse
233
References
235
32 Acute Airway Obstruction
238
Emergency Examination
238
Emergency Stabilization
238
Diagnostics
239
Complications of Upper Airway Obstruction
240
Diseases Causing Upper Airway Obstruction (Table 32.1)
240
Diseases of the Nasal Passage and Nasopharynx
240
Diseases of the Larynx and Pharynx
241
Diseases of the Trachea and Bronchi
242
References
243
33 Exacerbations of Chronic Bronchitis
247
Introduction
247
Disease Syndrome
247
Diagnosis
247
Treatment (Table 33.1)
248
Causes of Exacerbation
248
Airway Collapse
248
Mucus Obstruction
248
Bronchiectasis
249
Infection
249
Pulmonary Hypertension
250
Obesity Hypoventilation Syndrome
250
Emergency Management of Disease Exacerbations
250
References
251
34 Feline Lower Airway Disease
252
Introduction
252
Patient History
252
Initial Assessment
252
Emergency Treatment
252
Differential Diagnosis
253
Feline Asthma
253
Chronic Bronchitis
254
Lungworm Disease
254
Heartworm-Associated Respiratory Disease
254
References
255
35 Puppy Pneumonia
257
Introduction
257
Clinical Approach
258
Diagnostic Testing
258
Treatment Options
259
Prognosis
260
Brachycephalic Dogs
260
References
260
36 Coughing and Hemoptysis
261
Introduction
261
Physiology
261
Differential Diagnosis
262
Hemoptysis
262
Infectious Tracheobronchitis
262
Foreign Body
262
Anatomical Disruption
263
Neoplasia
263
Diagnostic Approach
263
Treatment
264
References
264
37 Bronchopneumonia
266
Introduction
266
Types of Pneumonia
266
Bacterial Pneumonia
266
Aspiration Pneumonia
267
Viral Pneumonia
267
Fungal Pneumonia
267
Protozoal Pneumonia
267
Parasitic Pneumonia
267
Physical Examination Findings
267
Diagnostics
268
Diagnostic Imaging
268
Clinicopathological Evaluation
269
Lung Function and Hemodynamic Monitoring
269
Airway Sampling for Cytology and Microbiology
269
Treatment
270
Antimicrobials
270
Supportive Care
270
Long-Term Therapy
270
Prognosis
271
References
272
38 Cardiogenic Pulmonary Edema
274
Introduction
274
Diuretics
274
Vasodilators
275
Positive Inotropes
277
Vasopressors
278
Sedatives
278
Oxygen Therapy
278
Other Therapies
278
References
278
39 Neurogenic Pulmonary Edema
279
Introduction
279
Pathogenesis
279
Blast Theory [1]
279
Direct Pulmonary Vascular Effect
280
Summary of Pathogenesis
280
Clinical Characteristics of Neurogenic Pulmonary Edema
280
Diagnosis
281
Initial Approach and Management
282
Monitoring the Effectiveness of Therapy
283
Prognosis
284
References
284
40 Submersion Injury
285
Introduction
285
Definitions
285
Precipitating Factors
285
Pathophysiology
285
Complications of Submersion Injury
286
Diagnosis and Treatment
287
Outcome
290
References
290
41 Pulmonary Hemorrhage
292
Etiology and Pathogenesis
292
Etiology
292
Pathogenesis
293
Patient Evaluation
293
History and Physical Examination Findings
293
Diagnosis
294
Radiography
294
Lung Ultrasound (see Chapter 182)
294
Computed Tomography
294
Echocardiography
294
Transtracheal Wash, Bronchoalveolar Lavage, Cytopathology, Histopathology, and Culture
294
Hematology: Complete Blood Count, Serum Chemistry, Coagulation Testing, and Other Laboratory Tests
295
Advanced Pulmonary Testing
295
Treatment
296
Outcome
296
References
296
42 Pulmonary Thromboembolism
298
Introduction
298
Risk Factors
298
Pathophysiology
298
Clinical Signs
299
Diagnosis
299
Coagulation Testing
299
Thoracic Radiographs
299
Arterial Blood Gas
300
Echocardiography
300
CT Pulmonary Angiography
301
Biomarkers
302
Management
302
Mechanical Ventilation
302
Anticoagulants and Thrombolytics
302
References
303
43 Primary and Metastatic Pulmonary Neoplasia
305
Introduction
305
Diagnostic Tests
306
Imaging
306
Laboratory Tests
306
Treatment and Prognosis
307
Pulmonary Carcinoma
307
Metastatic Pulmonary Nodules
307
Mesothelioma and Carcinomatosis
307
Conclusion
308
References
308
44 Pneumothorax
310
Anatomy
310
Pathogenesis
310
Traumatic Pneumothorax
310
Iatrogenic Pneumothorax
310
Spontaneous Pneumothorax
310
Clinical Consequences of Pneumothorax
312
Physical Examination
312
Diagnosis
312
Thoracocentesis
312
Ultrasound (see Chapter 182)
312
Radiography
313
Computed Tomography
313
Determining the Underlying Cause of Pneumothorax
313
Treatment
313
Thoracostomy Tubes
313
Continuous Suction
314
Pleurodesis and Blood Patching
314
Lung Lobectomy
314
Medical Therapy for Secondary Spontaneous Pneumothorax
314
References
315
45 Pleural Effusion
317
Introduction
317
Clinical Signs
317
Initial Treatment
317
Types of Effusions
318
Transudates
318
Hemorrhagic Effusion
319
Neoplastic Effusion
319
Exudates
319
Chylous Effusions
320
Conclusion
321
References
321
46 Pyothorax
323
Introduction
323
Etiology
323
Microbiology
323
Signalment
324
Clinical Signs and Physical Examination Findings
324
Diagnosis
324
Clinicopathological Findings
324
Thoracic Imaging
324
Treatment
325
Antimicrobial Therapy
326
Thoracic Drainage
326
Thoracic Lavage
326
Surgical Management
327
Prognosis
327
References
327
47 Diaphragmatic Hernia
330
Anatomy
330
Types of Hernias
330
Congenital
330
Acquired
330
Clinical Signs
331
Congenital
331
Acquired
331
Diagnosis
331
Physical Examination
331
Diagnostic Imaging
331
Laboratory Assessment
332
Treatment
332
Surgical Intervention
332
Postoperative Care
333
Complications and Prognosis
333
References
333
48 Penetrating Thoracic Trauma
336
Introduction
336
Etiology
336
Physical Examination and Diagnostics
336
Treatment
337
Fluid and Blood Products
337
Respiratory Stabilization
337
Pain Management
338
Antibiotics
338
Surgical Indications and Procedures
338
Anesthetic Considerations
339
Surgical Management
339
Prognosis
339
References
339
49 Blunt Thoracic Trauma
341
Introduction
341
Etiology
341
Pathophysiology
341
Physical Examination and Diagnostics
343
Treatment
343
Surgical Indications
344
Prognosis
345
References
345
50 Look-Alike Causes of Respiratory Distress
348
Introduction
348
Look-Alike Causes of Respiratory Distress
348
Decreased Oxygen Delivery (DO2)
348
Acid–Base Disorders
349
Brain Disease
349
Behavioral and Thermal Receptor Causes
349
Drugs
349
References
350
C. Cardiovascular Disease
351
51 Mechanisms of Heart Failure
353
What is Heart Failure?
353
Neuroendocrine Systems in Heart Failure
353
Maladaptive Responses in Heart Failure
354
Global Cardiac Function in Heart Failure
354
Treatment
355
Conclusion
355
References
355
52 Congenital Cardiovascular Disease
357
Introduction
357
Diagnosis
357
Cyanosis
357
Congestive Heart Failure
359
Syncope/Collapse
359
Conclusion
360
References
360
53 Arrhythmias
361
Introduction
361
Tachycardias
362
Supraventricular Tachycardia
362
Ventricular Tachycardia
362
Treating Supraventricular Tachycardias
363
Treating Ventricular Tachycardias
363
Bradycardias
365
References
367
54 Pericardial Effusion
368
Etiology
368
Pathophysiology
369
Clinical Presentation
369
Diagnostic Testing
369
Pericardiocentesis
370
Management and Prognosis
370
References
371
55 Dilated Cardiomyopathy
373
Introduction
373
Etiology
373
Signalment, Prevalence, and Incidence
373
Stages
373
Diagnosis
374
Presentation, Clinical Signs, and Physical Examination Findings
374
Diagnostic Tests
374
Electrocardiographic Findings
374
Focused Ultrasound Findings
375
Thoracic Radiographic Findings
375
Echocardiographic Findings
375
NT-proBNP Testing
376
Other Ancillary Tests
376
Treatment
376
Prognosis
379
References
379
Further Reading
380
56 Feline Hypertrophic Cardiomyopathy
381
Introduction and Definitions
381
Pathology and Pathophysiology
381
Diastolic Dysfunction and Congestive Heart Failure
381
Arterial Thromboembolism
381
Presentation and Clinical Signs
381
Initial Stabilization
382
Congestive Heart Failure
382
Arterial Thromboembolism
382
Diagnostic Tests
383
Thoracic Radiography
383
Echocardiography
383
Biomarkers
383
Other Diagnostics
384
Chronic Therapy
385
Prognosis
385
References
385
57 Valvular Heart Disease
387
Introduction
387
Myxomatous Valvular Degeneration
387
Diagnosis (Table 57.1)
387
Signalment and Historical Findings
387
Physical Examination
388
Echocardiography
388
Focused Assessment by Sonographic Technique
389
Radiography
389
Biomarkers
389
Pathophysiology of Congestive Heart Failure (see Chapter 51)
389
Left-Sided Congestive Heart Failure
389
Right-Sided Congestive Heart Failure
390
Pulmonary Hypertension Due to Left-Sided Heart Disease
390
Left Atrial Tears
391
Treatment (Table 57.2)
391
Prognosis
392
References
392
58 Heartworm Disease
394
Introduction
394
Pathophysiology
394
Clinical Presentation and Physical Examination
395
Diagnosis (Table 58.1)
396
Serology
396
Radiography
397
Echocardiography
398
Clinical Pathology
399
Treatment of Specific Syndromes
399
Eosinophilic Pneumonitis
399
Heartworm Disease in Cats and Heartworm-Associated Respiratory Disease
399
Pulmonary Thromboembolism
399
Right-Sided Congestive Heart Failure
399
Caval Syndrome
400
Complications After Microfilaricidal or Adulticidal Therapy
400
References
401
59 Pulmonary Hypertension
404
Pathophysiology
404
Defining Pulmonary Hypertension
404
Pulmonary Hypertension at the Cellular Level
404
Classification of Pulmonary Hypertension
404
Common Veterinary Causes of Pulmonary Hypertension
405
Cor Pulmonale
405
Definition and Description
405
Clinical Presentation
405
Patient Signalment and History
405
Recognizing Pulmonary Hypertension
406
Patient History
406
Diagnosis
406
Emergent Diagnostics
406
Completing the Diagnostic Plan
406
Treatment
407
Therapy in the Acute Setting
407
Long-Term Therapy Options
410
Follow-Up and Prognosis
410
References
410
60 Bradyarrhythmias and Pacemakers
412
Introduction and Definitions
412
Physiological Bradyarrhythmias
412
Iatrogenic Bradyarrhythmias
412
Pathological Bradyarrhythmias
412
Atrioventricular Block (AVB)
413
Sick Sinus Syndrome
414
Persistent Atrial Standstill
414
Clinical Management of Dogs and Cats with Bradyarrhythmias
414
Initial Stabilization
414
Indications for Permanent Pacing
416
Work-Up of Dogs and Cats with Bradyarrhythmias
416
References
416
61 Myocarditis
417
Introduction
417
Parvovirus
417
Chagas’ Disease
417
Lyme Disease
417
Bartonella
418
Toxoplasmosis
418
Traumatic Myocarditis
418
Diagnosis
418
Treatment
419
Further Reading
419
62 Thromboembolic Disease
420
Introduction
420
Pathophysiology of Thrombosis
420
Diagnosis of Thrombosis
420
General Aspects of the Treatment and Prevention of Thrombosis
421
Feline Aortic Thromboembolism
422
Canine Aortic Thrombosis
423
Portal Vein Thrombosis
423
Splenic Thrombosis
424
Mesenteric Thrombosis
424
Caval Thrombosis
424
Cerebral Infarction
425
Myocardial Thrombosis
425
References
426
63 Systemic Arterial Hypertension
429
Introduction
429
Pathophysiology of Systemic Hypertension
429
Target Organ Damage Caused by Systemic Hypertension
430
Neurological Target Organ Damage
430
Ocular Target Organ Damage
430
Cardiovascular Target Organ Damage
430
Renal Target Organ Damage
430
Conditions Associated with Systemic Hypertension
431
Clinical Recognition of Systemic Hypertension
431
Clinical Presentation
431
Blood Pressure Measurement
431
Treatment of the Patient with Systemic Hypertension
432
Prognosis and Long-Term Management
432
References
434
D. Hematological and Oncological Disorders
437
64 Leukocytosis and Leukopenia
439
Introduction
439
Leukocytosis
439
Neutrophilia
439
Neoplasia
440
Other Cell Lines
441
Treatment
441
Leukopenia
441
Neutropenia
441
Lymphopenia
442
Treatment
441
References
443
65 Non-Regenerative Anemia
445
Introduction
445
Erythropoiesis
445
Pathophysiological Response to Non-Regenerative Anemia
445
Diagnostic Approach
445
Bone Marrow Sampling and Analysis
447
Primary Bone Marrow Disorders
447
Secondary Extramarrow Disorders
448
Therapies for Non-Regenerative Anemia
448
References
449
66 Hemolytic Anemia
451
Introduction
451
History and Physical Examination
451
Laboratory Assessment
451
Differential Diagnoses for Hemolytic Anemia
451
Immune-Mediated Hemolytic Anemia (IMHA)
451
Alloimmune Hemolytic Anemia
453
Oxidative Hemolysis
453
Zinc and Copper Toxicity
453
Erythroparasites
454
Inherited Erythrocyte Defects
455
Microangiopathic Hemolysis
455
Hypophosphatemia
455
References
456
67 Thrombocytopenia
459
Platelets
459
Thrombocytopenia Etiology
459
Clinical Signs
460
Diagnosis
460
Treatment
460
References
461
68 Fibrinolysis and Antifibrinolytics
462
Introduction
462
Physiology of Fibrinolysis
462
Disorders of Fibrinolysis
463
Hyperfibrinolysis
463
Hypofibrinolysis
464
Evaluation of the Fibrinolytic System
464
D-dimers
464
Euglobulin Clot Lysis Time (ECLT)
464
tPA Assays
465
Plasminogen
465
Plasminogen Activator Inhibitor-1
465
Thrombin-Activatable Fibrinolysis Inhibitor
465
Alpha-2-Antiplasmin
465
Viscoelastic Testing
465
Management of Hyperfibrinolysis
466
Therapeutic Fibrinolysis
467
References
468
69 Congenital Coagulopathy
472
Introduction
472
Dogs
472
Cats
472
Animals Presenting with Unexplained Hemorrhage
472
Animals with Known Inherited Defects
473
Von Willebrand’s Disease
474
Hemophilia A
474
Hemophilia B
474
Conclusion
474
References
474
70 Acquired Coagulopathy
476
General Approach
476
Anticoagulant-Associated Coagulopathy
476
Heparins
476
Antiplatelet Drugs
477
Novel Oral Anticoagulants
477
General Management
478
Specific Management
478
Disseminated Intravascular Coagulation
480
Pathogenesis
480
Diagnosis
481
Treatment
481
Acute Traumatic Coagulopathy
482
Hepatobiliary Disorders
482
Pathophysiology
482
Diagnosis and Treatment
483
Diagnosis and Treatment
483
Neoplasia
483
References
484
71 Antithrombotics in the Emergency Room
487
Introduction
487
References
490
72 Sick Oncology Patients in the Emergency Room
491
Introduction
491
Febrile Neutropenia and Sepsis
491
Hypercalcemia
492
Acute Tumor Lysis Syndrome
494
Thromboembolism and Hemostatic Abnormalities
494
Hemangiosarcoma
495
Conclusion
496
References
496
73 Paraneoplastic Syndromes
499
Hypercalcemia of Malignancy
499
Hypoglycemia
500
Polycythemia
500
Anemia
501
Thrombocytopenia
501
Coagulopathies/Disseminated Intravascular Coagulation
501
Hypertrophic Osteopathy
502
Fever
502
Miscellaneous
502
References
502
E. Esophageal and Abdominal Disease
505
74 Vomiting and Regurgitation
507
Vomiting
507
Physiology
507
Sequelae of Vomiting
507
Diagnostics
507
Therapy
509
Regurgitation
510
Physiology
510
Sequelae
510
Diagnostics
510
Treatment
511
References
511
75 Esophageal Foreign Bodies
513
Introduction
513
Presentation
513
Diagnosis
513
Treatment
514
Outcome
515
Esophagitis
515
Esophageal Perforation
515
Esophageal Stricture
515
References
516
76 Diarrhea
517
Introduction
517
Diagnostic Approach
517
Causes of Diarrhea (Table 76.1)
518
Primary Gastrointestinal Disease
518
Extraintestinal Diseases
519
Treatment
520
Supportive Treatment
520
Fluid Therapy
520
Antiparasitic and Antimicrobial Therapy
520
Dietary Therapy
520
Other Therapies
520
References
521
77 Hematemesis and Gastrointestinal Hemorrhage
522
Introduction
522
Etiology and Pathophysiology
523
Clinical Signs and Physical Examination
524
Laboratory Evaluation
524
Diagnostic Imaging
525
Endoscopy
525
Exploratory Laparotomy
525
Treatment
525
Prognosis
526
References
526
78 Parvovirus Enteritis
528
Pathogenesis
528
Clinical Signs
528
Diagnostic Tests
529
Treatment and Monitoring
529
Prognosis
531
Husbandry Considerations
531
References
531
79 Hemorrhagic Gastroenteritis
533
Introduction
533
Investigation into the Underlying Etiology
533
Clinical Recognition and Diagnosis
534
Emergency Stabilization and Treatment
535
Prognosis
536
References
536
80 Protein-Losing Enteropathy
538
Introduction
538
Pathophysiology
538
Clinical Presentations and Laboratory Data
539
Treatment
539
Hypoalbuminemia
539
Hypercoagulability
540
Nutritional and Fluid Support
540
Calcium Homeostasis
540
Immunosuppressive Therapy
540
Prognosis and Follow-Up Care
540
Protein-Losing Enteropathy in Feline Patients
541
References
541
81 Gastrointestinal Obstruction
543
Introduction
543
Etiology
543
Pathophysiology
543
Clinical Signs and Physical Exam
544
Diagnostics
545
Radiography
545
Specific Conditions
547
Non-Obstructive Foreign Body
547
Linear Foreign Bodies
548
Intussusception
548
Postoperative Complications and Care
548
Overview
549
References
549
82 Gastric Dilation-Volvulus
552
Introduction
552
Diagnosis and Treatment
552
Surgical Management
554
Outcome
554
References
554
83 Mesenteric Torsion
556
Introduction
556
Pathophysiology
556
History and Clinical Signs
557
Diagnostics
557
Treatment
558
References
559
84 Hemoperitoneum
560
Introduction
560
History and Signalment
560
Clinical Signs and Physical Examination Findings
560
Initial Treatment and Stabilization
561
Diagnostics
562
Definitive Care and Prognosis
564
References
565
85 Splenic Disease
567
Splenic Disease in the Emergent Patient
567
Splenic Masses in Dogs
567
Splenic Torsion
569
Splenic Trauma
570
Splenic Infarction
570
Splenic Abscesses
570
Miscellaneous Conditions Causing Diffuse Splenomegaly in Dogs
570
Feline Splenic Disease
570
References
571
86 Pancreatitis
573
Introduction
573
Pathophysiology
573
History, Signalment, and Clinical Signs
573
Diagnosis
574
Diagnostic Imaging
575
Fluid Analysis
576
Biopsy and FNA
576
Scoring Disease and Assessing Severity
576
Treatment
576
Prognosis and Owner Communication
578
References
578
87 Peritonitis
582
Introduction
582
Etiology
583
Immune Response
583
Signalment and History
583
Physical Examination
583
Diagnostics
584
Treatment
585
Fluid Therapy
585
Antimicrobial Therapy
585
Pain Management
585
Antiemetics, Antacids, and Prokinetics
586
Nutrition
586
Prognosis
586
References
587
88 Postoperative Complications Presenting to the Emergency Service
588
Introduction
588
Surgical Site Complications
588
Associated Complications
591
Conclusion
591
References
591
89 Biliary Disease
593
Introduction
593
Overview of Anatomy and Physiology
593
Presenting Signs and Initial Physical Examination
594
Diagnostics
594
Stabilization
594
Cardiovascular System
594
Respiratory System
595
Neurological System
595
Acute Medical Therapy
595
Surgery
595
Prognosis
597
References
597
90 Acute Liver Failure
598
Introduction
598
Pathophysiology
598
Presenting Complaint and Clinical Signs
599
Cardiovascular Signs
600
Respiratory Signs
600
Neurological Signs
600
Renal Signs
600
Causes
600
Diagnostic Tests
603
Emergency Stabilization and Treatment
604
Prognosis
607
Conclusion
607
References
607
91 Feeding Tube Complications
610
Introduction
610
Complications Associated with Placement of Feeding Tubes
610
Complications Associated with Feeding Tube Use
611
Complications Encountered After Placement of Feeding Tubes
611
Conclusion
612
References
613
92 Anorectal Disease
614
Introduction
614
Anatomy
614
Perforation
614
Rectal Prolapse
616
Other Diseases
617
Anal Sac Diseases
617
Rectal Neoplasia
617
Perianal Fistulae
617
References
618
93 Constipation
619
Introduction
619
History
619
Physical Examination
620
Diagnostics
620
Treatment
621
Disimpaction of Feces
621
Maintenance Therapy
622
Prognosis
622
References
622
F. Urogenital Disorders
710
94 Acute Azotemia
712
Introduction
712
Prerenal Azotemia
713
Intrinsic Renal Azotemia
713
Postrenal Azotemia
713
Diagnosis of Acute Azotemia
714
Physical Examination and History
714
Initial Diagnostics
715
Treatment
715
References
716
95 Oliguria
718
Pathogenesis of Oligoanuria
718
Patient Assessment and Initial Diagnostics
718
Managing the Oligoanuric Patient
719
Converting Oligoanuria to Polyuria
720
Extracorporeal Renal Replacement Therapy
721
References
721
96 Urinary Tract Infections
723
Definition
723
Incidence and Pathogenesis
724
History and Physical Examination
725
Diagnosis
726
Therapy
728
Management of Particular Conditions
734
Subclinical Bacteriuria
734
Urinary Tract Infections Associated with Urinary Catheters
734
Acute Prostatitis
735
Acute Pyelonephritis
735
References
736
97 Urolithiasis
737
Introduction
737
Diagnosis of Uroliths
737
Management of Uroliths Associated with Urinary Obstruction
738
Management of Uroliths Unassociated with Urinary Obstruction
738
Medical Treatment
738
Minimally Invasive Techniques
740
Surgical Treatment
740
References
741
98 Feline Ureteral Obstruction: Diagnosis and Management
744
Introduction
744
Etiology
744
Treatment of Feline Ureteral Obstructions
745
Traditional Surgery
745
Interventional Options
746
Postoperative Management
749
Conclusion
750
References
750
99 Feline Lower Urinary Tract Obstruction
751
Pathogenesis of Obstruction
751
Predisposing Factors
751
Pathophysiology of Obstruction
751
History and Clinical Signs
752
Initial Stabilization
752
Urethral Catheterization
753
Diagnostic Evaluation
755
Postobstructive Care
755
Alternative Management Protocols
755
At-Home Care
756
Prognosis
756
References
756
100 Urethral Trauma
758
Incidence
758
Patient Evaluation
758
Diagnosis
758
Treatment
759
Conservative Management
759
Surgical Management
760
Complications
761
Stricture Management
761
Outcome
761
References
761
101 Lyme Nephritis
763
Introduction
763
Transmission, Prevalence, and an Experimental Model of Canine Lyme Disease
763
Presentation of Field Cases with Presumptive Lyme Nephritis [1–4,15]
764
Diagnostic Work-Up to Stage Disease and Rule Out Other Differentials [1–4,9,10]
764
Renal Biopsy
766
Treatment (Table 101.2)
766
Monitoring
767
Prevention, Tick Control and Lyme Vaccination
768
References
768
102 Chronic Kidney Disease
770
Introduction
770
Pathophysiology
770
Presentation
771
Diagnostics
771
Laboratory Tests
771
Imaging
771
Monitoring
771
Stabilization and Initial Therapy
771
Fluid Therapy
771
Management of Anemia
772
Hypertension (see Chapter 63)
772
Management of Gastrointestinal Signs
772
Dose Reduction
773
Prognosis and Long-Term Management
773
Conclusion
774
References
774
103 Uroabdomen
776
Etiology and Pathogenesis
776
Clinical Signs and Physical Examination Findings
777
Diagnosis and Laboratory Evaluation
777
Laboratory Findings
777
Imaging Findings
777
Emergent Stabilization
778
Treatment
779
Complications and Prognosis
779
References
780
104 Urethral Prolapse
782
Urethral Prolapse
782
Diagnosis
782
Treatment
782
References
783
105 Discolored Urine
784
Introduction
784
Examination of the Urine Specimen
784
Abnormal Urine Sediment Color
784
Hematuria
784
Other Cells or Particles
785
Abnormal Urine Supernatant Color
785
Endogenous Pigments
785
Exogenous Pigments
787
Multifactorial Urine Discoloration
787
Pigment-Induced Renal Injury
788
Conclusion
788
References
788
106 Urinary Diversion in the Emergency Room
790
Urinary Catheterization
790
Indications
790
Contraindications
790
Complications
790
Percutaneous Nephrostomy Tube
791
Indications
791
Complications
792
Percutaneous Antegrade Urethral Catheterization
792
Indications
792
Complications
792
Cystoscopy and Urethroscopy
793
Indications
793
Complications
793
Cystostomy Tubes
794
Indications
794
Complications
795
Peritoneal Drainage
795
Indications
795
Complications
795
References
795
G. Acid-base, Electrolyte and Endocrine Disorders
798
107 Acid–Base Disorders
800
Introduction
800
Sample Considerations
800
Acid–Base Regulation
800
Acid–Base Analysis
801
Evaluate pH
801
Determine the Primary Disorder
801
Compensation
801
Primary Versus Mixed Disorders
802
Acid–Base Disorders
802
Respiratory Alkalosis
802
Respiratory Acidosis
802
Metabolic Alkalosis
803
Metabolic Acidosis
803
Acid–Base and Prognosis
804
Case Example 1
804
Case Example 2
804
Case Example 3
805
References
805
108 Sodium and Water Balance
807
Introduction
807
Hyponatremia
808
Etiology
808
Clinical Signs
808
Diagnosis
808
Treatment
809
Hypernatremia
811
Etiology
811
Clinical Signs
812
Diagnosis
812
Treatment
812
Prognosis
813
References
813
109 Potassium Disorders
817
Introduction
817
Potassium Homeostasis
817
Hypokalemia
817
Definition and Etiology
817
Symptoms
818
Treatment
819
Hyperkalemia
819
Definition and Etiology
819
Symptoms
821
Treatment
822
References
823
110 Calcium, Magnesium, and Phosphorus Disorders
826
Introduction
826
Phosphorus Homeostasis
826
Hypophosphatemia
827
Hyperphosphatemia
829
Calcium Homeostasis
830
Hypocalcemia
830
Hypercalcemia
831
Magnesium Homeostasis
832
Hypomagnesemia
833
Hypermagnesemia
834
References
834
111 Hypoglycemia
836
Introduction
836
Pathophysiology
836
Clinical Signs
837
Causes of Hypoglycemia
837
Excess Secretion of Insulin or Insulin-Like Factors
837
Decreased Glucose Production
838
Excess Glucose Consumption
839
Drug-Associated Causes
839
Spurious
839
Diagnosis
839
Treatment of a Hypoglycemic Crisis
840
References
840
112 Hyperglycemia
843
Introduction
843
Stress Hyperglycemia
843
Diabetes Mellitus
844
Insulin Deficiency and Insulin Resistance
844
References
845
113 Complicated Diabetes Mellitus
846
Introduction
846
Pathogenesis
846
History and Physical Examination
846
Diagnostic Evaluation in the Emergency Room
847
Triage Panel
847
Measure Blood Glucose Concentration
847
Measure Ketones and Assess Degree of Acidemia
847
Quantify Degree of Hyperosmolality
847
Assess Electrolyte Abnormalities
847
Stabilization and Emergency Treatment
848
Restore Effective Circulating Volume (see Chapter 153)
848
Provide Ongoing Fluid Therapy
848
Treat Electrolyte Abnormalities
848
Initiate Insulin Therapy
849
Identify and Treat Concurrent Diseases
850
Post-crisis Therapy for Diabetes Mellitus
850
Outcome
850
References
851
114 Adrenal Gland Disorders
853
Introduction
853
Pheochromocytoma
853
Incidence
853
Pathophysiology
853
Clinical Signs and Physical Examination
853
Diagnostic Results
854
Treatment
854
Surgical Outcome and Prognostic Factors
854
Hyperaldosteronism
854
Incidence
855
Pathophysiology
855
Clinical Signs and Physical Examination
855
Diagnostic Results
855
Treatment and Prognosis
855
Hyperadrenocorticism
855
Pathophysiology
856
Clinical Signs and Physical Examination
856
Diagnostic Results
856
Treatment and Prognosis
856
References
857
115 Hypoadrenocorticism
859
Etiology and Pathogenesis
859
Anatomy and Pathophysiology
859
Mineralocorticoid Deficiency
860
Glucocorticoid Deficiency
860
Patient Evaluation
860
History and Physical Examination Findings
860
Feline Hypoadrenocorticism
862
Diagnosis
862
Emergency Cage-Side Tests and Imaging
862
Complete Blood Count (CBC)
862
Serum Chemistry Panel
862
Resting or Basal Serum Cortisol Levels
863
ACTH Stimulation Testing
863
Cortisol-to-Adrenocorticotropic Hormone Ratio
863
Primary Versus Secondary Hypoadrenocorticism
863
Treatment
864
Fluid Therapy
864
Hyperkalemia
864
Acidosis
865
Glucocorticoids
865
Chronic Management
865
Complications
866
Outcome
866
References
866
116 Thyroid Disorders
869
Introduction
869
Thyroid Physiology
869
Thyroid Testing
869
Hyperthyroidism
870
Hypothyroidism
870
Clinical Presentations
870
Hyperthyroidism
870
Hypertensive Retinopathy
871
Thyroid Storm
871
Iatrogenic Hyperthyroidism
871
Hypothyroidism
872
Myxedema Coma
872
References
872
117 Diabetes Insipidus
874
Introduction
874
Pathophysiology
874
Recognizing Diabetes Insipidus in the Emergency Patient
874
History
875
Physical Examination
875
Clinicopathological Abnormalities
876
Definitive Diagnosis
876
Treatment
876
Water Replacement
876
AVP Administration
877
Complications of Treatment – Cerebral Edema
877
Patient Discharge
877
Prognosis
877
References
877
H. Reproductive Disorders
880
118 Dystocia
882
Female Reproductive Anatomy and the Physiology of Parturition
882
Anatomy
882
Physiology of Parturition
882
Estimating Expected Date of Parturition
883
Stages of Parturition
883
Dystocia
883
Risk Factors
883
Classifying Dystocia
883
When is Examination of the Bitch or Queen Warranted?
884
Clinical Examination
884
Diagnostics
884
Indicators for Intervention
885
Medical Management of Dystocia
885
Surgical Management
885
Postoperative Care and Management
886
References
886
119 Eclampsia
888
Introduction
888
Etiopathogenesis
888
Diagnosis
888
Treatment (Box 119.1)
889
Prevention
890
References
890
120 Neonatal Resuscitation
892
Physical Examination
892
Respiratory Concerns
893
Cardiac Concerns
893
Hypothermia
893
Dehydration and Fluid Therapy
894
Hypoglycemia
894
Sepsis
895
When to Stop Resuscitation Efforts
895
References
895
121 Diseases of the Neonate
896
Introduction
896
Epizootiology
896
Physiology
896
Neonatal Disorders in the Immediate Postpartum Period
897
Disorders of Metabolism
897
Anasarca
897
Ciliary Dyskinesia
898
Hydrocephalus
898
Umbilical Herniation
898
Bowel Malformation: Agenesis or Duplication
899
Patent Urachus
899
Cleft Palate
899
Neonatal Isoerythrolysis (see Chapter 66)
900
Immunodeficiency
900
Neonatal Ophthalmia
901
Limb Deformities: Amelia, Hemimelia (Absence of a Limb or Distal Portion of a Limb), Pelvic Limb Hyperextension
901
Neonatal Disorders in the Later Postpartum Period
901
Orphans
901
Aspiration Pneumonia
902
Swimmer Puppies
902
Juvenile Cellulitis
902
Bacterial Overgrowth Syndrome-Associated Diarrhea
903
Urinary Ectopia
904
Hypoglycemia
904
Fading Puppy Syndrome: Neonatal Bacterial Septicemia and Herpes Infection (CHV-1)
905
Trauma
906
References
906
122 Metritis and Mastitis
908
Metritis
908
Clinical Signs
908
Diagnostics
908
Treatment
909
Mastitis
909
Clinical Signs
909
Diagnostics
909
Treatment
910
References
910
123 Pyometra
912
Signalment, Clinical Presentation, and Associated Disease
912
Diagnostics
912
Treatment
913
Stabilization
913
Antibiotic Therapy
913
Surgical Versus Medical Management
913
Surgical Management
913
Medical Management
914
References
917
124 Prostatic Disease
919
Introduction
919
Anatomy
919
Diagnostics
919
Prostatic Disorders
920
Benign Prostatic Hyperplasia and Cystic Benign Prostatic Hyperplasia
920
Squamous Metaplasia
920
Paraprostatic Cysts
921
Infectious Prostatitis
921
Prostatic Neoplasia
922
References
923
125 Uterine and Vaginal Prolapse
924
Uterine Prolapse
924
Etiopathogenesis
924
Diagnosis
924
Treatment
924
Vaginal Prolapse
925
True Vaginal Prolapse
925
Vaginal Fold Prolapse (Canine Only)
926
References
928
126 Penile, Preputial, and Testicular Disease
929
Priapism
929
Pathophysiology
929
Clinical Presentation
929
Diagnostics
929
Therapy
930
Paraphimosis
931
Pathophysiology
931
Clinical Presentation
931
Diagnostics
931
Therapy
931
Phimosis
932
Pathophysiology
932
Clinical Presentation
932
Diagnostics
932
Therapy
932
Persistent Penile Frenulum
932
Pathophysiology
932
Clinical Presentation
932
Diagnostics
932
Therapy
932
Balanoposthitis
932
Pathophysiology
932
Clinical Presentation
932
Diagnostics
932
Therapy
933
Urethral Prolapse (see Chapter 104)
933
Pathophysiology
933
Clinical Presentation
933
Diagnostics
933
Therapy
933
Penile Trauma
933
Pathophysiology
933
Clinical Presentation
933
Diagnostics
933
Therapy
933
Infectious Orchitis and Epididymitis
933
Pathophysiology
933
Clinical Presentation
933
Diagnostics
934
Therapy
934
Testicular Torsion
934
Pathophysiology
934
Clinical Presentation
934
Diagnostics
934
Therapy
934
Scrotal Dermatitis
934
Pathophysiology
934
Clinical Presentation
934
Diagnostics
934
Therapy
934
References
935
I. Common Toxins
936
127 Decontamination and Toxicological Analyses of the Poisoned Patient
938
Introduction
938
Gastrointestinal Decontamination
938
Emetic Agents
938
Gastric Lavage
940
Activated Charcoal
942
Multidose Activated Charcoal
944
Complications
944
Administration of Charcoal
944
Toxicological Analyses
944
Conclusion
946
References
946
128 Lipid “Rescue” Therapy
948
Introduction
948
Available Formulations
948
Historical Use in Human Medicine
948
Use in Veterinary Medicine
949
Mechanism of Action
949
Recommended Dosing
950
Potential Complications
950
References
951
129 Blood Purification Techniques for Intoxications
952
Introduction
952
Intermittent Hemodialysis
952
Prolonged Intermittent HD and Continuous Therapies
953
Hemoperfusion
953
Combination Hemodialysis/Hemoperfusion
953
Apheresis
954
Indications for the Use of Extracorporeal Therapies in Treatment of Poisoning
955
Medical Management for Intoxications
956
Conclusion
956
References
956
130 Rodenticide Toxicity
958
Introduction
958
Decontamination
958
Anticoagulant Rodenticides
958
Neurotoxic Rodenticides
960
Cholecalciferol Rodenticides
961
Phosphide Rodenticides
961
Aldicarb Rodenticide
962
References
962
131 Ethylene Glycol Intoxication
963
Introduction
963
Clinical Signs
963
Diagnostic Testing
964
Treatment
965
Hemodialysis
966
References
966
132 Acetaminophen Intoxication
968
Introduction
968
Pharmacokinetics and Toxicokinetics
968
Toxic Doses
969
Clinical Signs
969
Gross and Histological Lesions
969
Diagnosis
969
Treatment
970
N-Acetylcysteine
970
Ascorbic Acid
970
Silymarin
971
Histamine Receptor Antagonists
971
S-Adenosyl Methionine
971
Methylene Blue
971
Prognosis
971
References
971
133 Non-Steroidal Anti-Inflammatory Drug Intoxications
973
Mechanism of Action
973
Pharmacokinetics
974
Adverse Effects
974
Gastrointestinal Toxicity
974
Renal Injury
974
Hepatic Injury
974
Coagulation and Hematological Issues
974
Neurological Complications
976
Treatment of NSAID Intoxication
976
References
977
134 Grape, Raisin, and Lily Ingestion
979
Grape, Raisin, and Currant Nephrotoxicity Pathogenesis
979
Lily Nephrotoxicity Pathogenesis
979
Physical Examination
980
Initial Diagnostics
980
Management of Non-Azotemic Animals Shortly After Exposure
980
Managing Patients with Established Acute Kidney Injury
981
Prognosis
981
References
981
135 Recreational Drug Intoxications
983
Cocaine
983
Mechanism and Toxicokinetics
983
Clinical Signs
983
Differential Diagnoses
983
Diagnostics
983
Treatment
983
Prognosis
984
Methamphetamine
984
Mechanism and Toxicokinetics
984
Clinical Signs
984
Diagnostics and Treatment
984
Differential Diagnoses
984
Prognosis
984
Marijuana
985
Mechanism and Toxicokinetics
985
Clinical Signs
985
Differential Diagnoses
985
Diagnostics
986
Treatment
986
Prognosis
986
Conclusion
986
References
987
136 Household Toxins
988
Decontamination
988
Common Household Toxin Exposures
988
Foods
988
Outdoor Products
989
Cleaning Products
990
Foreign Objects
990
Conclusion
991
References
991
J. Skin and Soft Tissue Disease
992
137 Life-Threatening Dermatological Emergencies
994
Dermatological Emergencies
994
Methicillin-Resistant Staphylococcal Infections (MRSIs)
994
Burns
995
Frostbite
997
Drug Eruption
998
Vasculitis
1000
Erythema Multiforme
1002
Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome
1004
References
1006
138 Severe Soft Tissue Infections
1009
Introduction
1009
Etiology
1009
Pathophysiology
1009
Clinical Features (Table 138.1)
1010
Diagnosis (see Table 138.1)
1010
Treatment (see Table 138.1)
1011
Prognosis
1012
References
1013
K. Environmental Emergencies
1014
139 Smoke Inhalation Toxicity
1016
Introduction
1016
Pathophysiology of Smoke Inhalation
1016
Carbon Monoxide and Cyanide Exposure
1017
Physical Examination Findings
1018
Diagnostics
1018
Treatment
1019
Prognosis
1019
References
1020
140 Porcupine Quilling
1022
Introduction
1022
Prehospital Care
1022
Quill Removal
1022
Discharge Instructions
1023
Complicated Quillings
1023
Conclusion
1024
References
1024
141 Crotalinae Snake Envenomation
1025
Introduction
1025
Crotalinae Envenomation
1025
Clinical Signs of Envenomation
1026
Patient Evaluation and Stabilization
1026
Antivenoms
1027
Additional Therapies
1028
References
1029
142 Elapid Snake Envenomation: North American Coral Snakes and Australian Elapids (Tiger Snakes, Brown Snakes, Taipans, Death Adders, and Black Snakes)
1031
Introduction
1031
Elapid Species Identification
1033
North America
1033
Australia
1033
Pathophysiology of Elapid Venoms
1033
Neurotoxins
1033
Procoagulant Toxins
1034
Anticoagulant Toxins
1034
Myotoxins
1034
Hemolytic Toxins
1034
Local-Acting Cytotoxins
1035
Clinical Signs of Envenomation
1035
Preparalytic Signs
1035
Paralysis
1035
Coagulopathy
1035
Rhabdomyolysis
1035
Hemolysis and Anemia
1036
First Aid Advice for Owners
1036
Treatment of Envenomation in Dogs and Cats
1036
Asymptomatic Patients
1036
References
1037
143 Spider and Scorpion Envenomation
1038
Spider Envenomation
1038
Loxoscelism
1038
Lactrodectism
1039
Theraphosidae Spiders
1040
Scorpion Envenomation
1040
Pathophysiology of Envenomation
1040
Clinical Effects of Scorpion Envenomation in People
1040
Treatment of Scorpion Envenomation in People
1041
Scorpion Envenomation in Dogs and Cats
1041
References
1042
144 Bufo Toad Toxicosis
1043
Introduction
1043
Incidence
1044
Signalment
1044
Clinical Signs of Envenomation
1044
Diagnosis
1045
Treatment and Monitoring
1045
Prognosis
1046
Acknowledgments
1046
References
1046
145 Hymenoptera Envenomation
1047
Apoidea
1047
Vespoidea
1047
Formicidea
1047
Venom
1048
Lethal Dose
1048
Clinical Manifestations of Envenomation
1048
Immune-Mediated Response
1048
Systemic Toxic Reactions
1049
Diagnosis
1049
Treatment
1049
Treatment of Systemic Anaphylaxis
1049
Treatment of Toxic and Delayed Reactions
1051
References
1051
146 Hypersensitivity and Anaphylaxis
1053
Incidence and Definitions
1053
Classification and Pathophysiology of Hypersensitivity Reactions and Anaphylaxis
1053
Etiologies and Clinical Manifestations
1054
Diagnosis
1055
Treatment
1056
Antihistamines
1056
Glucocorticoids
1056
Epinephrine
1056
Bronchodilators
1057
Intravenous Fluids and Other Ancillary Treatments
1057
Prognosis
1057
References
1057
147 Canine Heat Stroke
1059
Pathophysiology
1059
Risk Factors for Developing Heat Stroke
1059
Clinical Signs and Diagnosis
1060
Hematological Disorders and Biochemical Abnormalities
1060
Coagulation Disorders and Disseminated Intravascular Coagulation
1061
Other Complications: Acute Kidney Injury, Central Nervous System Dysfunction, ARDS, Cardiac Arrhythmias, and Gastrointestinal Bacterial Translocation
1062
Acute Kidney Injury
1062
Central Nervous System Dysfunction
1062
Acute Respiratory Distress Syndrome
1062
Cardiac Arrhythmias
1062
Gastrointestinal Bacterial Translocation
1062
Treatment Options
1064
Monitoring
1065
Prognosis
1065
Conclusion
1065
References
1065
148 Cold Exposure
1067
Introduction
1067
Pathophysiology of Effects of Cold Exposure [1–3,6–10]
1067
Management [1–3,7–10]
1069
Frostbite
1071
Pathophysiology [1,2,16,20]
1071
Management
1072
References
1072
149 Electrical and Lightning Injuries
1073
Introduction
1073
Electrical Injury
1073
Mechanisms of Electrical Injury
1073
Predisposition to Electrical Injury
1073
Clinical Findings
1074
Secondary Effects of Electrical Injury
1075
Treatment of Electrical Injury
1076
Prognosis
1076
Lightning Injury
1076
References
1077
Section 4 Trauma and Resuscitation
1080
A. Cardiopulmonary Resuscitation
1082
150 Cardiopulmonary Resuscitation in the Emergency Room
1084
Recognition of Cardiopulmonary Arrest
1084
Airway Assessment
1084
Breathing Assessment
1084
Diagnosis of CPA
1084
Basic Life Support
1084
Chest Compressions
1084
Ventilation
1087
Advanced Life Support
1087
Initiating ALS
1087
Interpreting the ECG
1088
Non-Shockable Arrest Rhythms
1089
Shockable Arrest Rhythms
1089
Prognosis
1090
References
1090
151 Small Animal Cardiopulmonary Resuscitation Initiatives
1091
Strategically Advancing the Field of Veterinary CPR
1091
Evidence-Based Consensus Small Animal CPR Guidelines
1091
Knowledge Gaps
1092
Glossary and Guidelines For Standardized Reporting
1092
CPR Registry
1094
Conclusion
1094
References
1094
B. Circulatory Shock
1096
152 Pathophysiology of Shock
1098
Introduction
1098
Cellular Impact
1098
Systemic Impact
1099
Secondary Systemic Sequelae
1100
Systemic Inflammatory Response
1100
Coagulopathy
1100
Mitochondrial Dysfunction
1101
Microcirculatory Dysfunction
1101
Multiple Organ Dysfunction Syndrome
1101
Conclusion
1101
References
1102
153 Hypovolemic Shock
1103
Pathophysiology of Hypovolemic Shock
1103
Decompensation
1104
Diagnosis of Hypovolemic Shock
1104
Physical Examination
1104
Blood Pressure
1105
Electrocardiogram
1105
Laboratory Tests
1105
Diagnostic Imaging
1106
Response to Treatment
1106
Emerging Diagnostic Techniques
1106
Treatment of Hypovolemic Shock
1107
Resuscitation Endpoints
1107
Complications of Hypovolemic Shock
1107
References
1108
154 Cardiogenic Shock
1110
Introduction
1110
Pathophysiology (see Chapter 152)
1110
Incidence and Etiology
1111
Diagnosis
1112
Physical Examination
1112
Electrocardiogram (ECG)
1113
Thoracic Radiography
1113
Laboratory Exam findings, Lactate, Biomarkers, and Arterial Blood Pressure
1113
Echocardiography
1113
Sublingual Microcirculation
1113
Treatment and Monitoring
1113
Conclusion
1115
References
1115
155 Additional Mechanisms of Shock
1117
Introduction
1117
Distributive Shock
1118
SIRS and Sepsis
1118
Anaphylaxis
1118
Hypoadrenocorticism
1118
Neurogenic Shock
1119
Obstructive Shock
1119
Cardiac Tamponade
1119
Pleural Space Disease
1119
Pulmonary Thromboembolism (see Chapters 42 and 62)
1119
Gastric Dilation-Volvulus
1119
Non-Circulatory Shock
1120
Decreased Oxygen Content
1120
Metabolic Aspects
1120
References
1120
156 Lactate Monitoring
1122
Introduction
1122
Lactate Physiology
1122
Causes of Hyperlactatemia
1122
Type 1 Hyperlactatemia without Acidosis
1122
Type 2A Lactic Acidosis
1123
Type 2B Lactic Acidosis
1123
Lactate Measurement
1123
Sample Handling
1124
Patient Selection
1124
Normal Lactate Concentration
1125
Assessment of Hyperlactatemia
1125
Prognostic Implications
1125
Lactate Measurement in Other Body Fluids
1126
References
1126
157 Emerging Monitoring Techniques
1128
Introduction
1128
Venous Oxygen Monitoring
1128
Peripheral Hemodynamic Parameters
1129
Temperature Gradient Monitoring
1129
Sublingual Capnometry
1131
Hemodynamic Component of Pulse Oximetry
1131
Plethysmogram Monitoring (Delta Ppleth)
1131
References
1133
158 Ischemia-Reperfusion Injury
1136
Pathophysiology
1136
Disorders Associated with Ischemia-Reperfusion Injury
1137
Identification of Ischemia-Reperfusion Injury
1139
Management of Ischemia-Reperfusion Injury
1139
Lidocaine
1140
N-Acetylcysteine
1140
Ischemic Preconditioning
1140
Deferoxamine
1140
Allopurinol
1140
Cyclosporine
1140
Remifentanil
1141
Conclusions and Clinical Recommendations
1141
References
1141
159 Systemic Inflammatory Response Syndrome, Sepsis, and Multiple Organ Dysfunction Syndrome
1147
Introduction
1147
Definitions
1147
Pathophysiology
1149
Diagnostic Approach to SIRS and Sepsis
1151
Treatment Approach to SIRS and Sepsis
1152
Treating Shock
1152
Treating Cardiovascular Dysfunction
1152
Antimicrobial Therapy (see Chapter 200)
1153
Source Control
1153
Supportive Care and Managing Organ Dysfunctions
1153
Prognosis for SIRS, Sepsis, and MODS
1153
References
1153
C. Trauma
1156
160 Trauma Overview
1158
Introduction
1158
Overview of the Pathophysiology of Trauma
1158
Epidemiology of Small Animal Trauma
1159
Trauma Scoring Systems
1160
General Approach to the Polytrauma Patient
1160
Considerations for Intravenous Fluid Resuscitation in Trauma
1163
References
1165
161 Trauma Center Registry
1169
Veterinary Trauma Initiative
1169
Trauma Registries: History and Purpose
1169
Trauma Registry: The Future
1169
Acknowledgments
1170
References
1170
162 High-Rise Syndrome
1171
Definition and Pathophysiology
1171
Clinical Signs
1171
Diagnostics
1173
Treatment
1174
Prognosis
1175
References
1176
163 Trauma-Associated Coagulopathy
1177
Introduction
1177
Pathogenesis
1177
Resuscitation-Associated Coagulopathy
1177
Acute Coagulopathy of Trauma-Shock
1178
Trauma-Associated Coagulopathy in Dogs
1180
Hemostatic Testing for Trauma
1181
Conclusion
1181
References
1182
164 Metabolic Consequences of Trauma
1185
Introduction
1185
Sympathoadrenal Activation
1185
Neuroendocrine Activation
1185
Hyperglycemia
1185
Hyperlactatemia
1186
Acid–Base Disorders
1186
Body Temperature
1186
Gastrointestinal Injury
1187
Systemic Inflammation
1187
Activation of the Coagulation Cascade
1187
Conclusion
1188
References
1188
165 Traumatic Orthopedic Emergencies
1189
General Considerations for the Trauma Patient
1189
Fractures
1189
Closed Fractures
1189
Open Fractures
1190
Decision Making for Fracture Repair
1190
Traumatic Joint Injuries
1191
Penetrating Injuries
1191
Traumatic Joint Luxation
1191
Miscellaneous Joint Injury
1192
Skull and Maxillofacial Trauma
1192
References
1194
166 Wound Management Principles
1196
Introduction
1196
Phases of Wound Healing
1196
Inflammation and Debridement Phase
1196
Repair (Proliferative) Phase
1197
Maturation Phase
1198
Wound Closure
1198
Management of Acute Traumatic Wounds and Deciding When and How to Close Them
1198
Initial Wound Care
1199
Deciding on Wound Closure
1200
“Freshening Wound Edges”
1202
Managing Wound Drainage
1202
Antibiotic Therapy in Wound Management
1203
Acute Wounds
1203
Infected Wounds
1203
References
1204
Section 5 Fluid and Blood Product Therapy
1206
167 Crystalloid Fluid Therapy
1208
Introduction
1208
Physiology of Fluid Distribution
1208
Patient Assessment
1208
Types of Crystalloids
1209
Crystalloid Fluids in Resuscitation
1211
Which Crystalloid Should We Use?
1211
How Much Fluid?
1211
Crystalloid Fluids for Rehydration and Maintenance
1212
Complications of Crystalloid Fluid Therapy
1212
References
1212
168 Colloid Fluid Therapy
1214
Introduction
1214
Colloid Osmotic Pressure
1214
Colloid Osmometry
1214
Types of Colloid Solutions
1215
Natural Colloids
1215
Synthetic Colloids
1216
Conclusion
1218
References
1218
169 Crystalloids Versus Colloids
1220
Introduction
1220
Suitability
1220
Fluid Prescription: Crystalloids (see Chapter 167)
1221
Indications
1221
Composition and Selection
1221
Adverse Effects
1222
Fluid Prescription: Colloids (see Chapter 168)
1223
Composition and Selection
1223
Natural Colloids
1223
Synthetic Colloids: Hydroxyethyl Starches
1224
Summary
1226
Fluids: Strategies, Dosages, and Endpoints
1226
References
1228
170 Management of Hemorrhagic Shock
1232
Signalment/History
1232
Physical Examination
1232
Point-of-Care Diagnostics
1233
Laboratory Testing
1233
Emergency Database
1233
Coagulation Assessment (see Chapters 69 and 70)
1233
Radiography and Ultrasound
1233
Treatment
1234
Limiting External Blood Loss
1234
Fluid Resuscitation
1234
Transfusion of Blood Products
1236
Alternatives to Blood Products
1236
Limiting Internal Hemorrhage
1237
Additional Therapy for Specific Conditions
1238
References
1240
Supplemental Reading
1242
171 Management of Dehydration
1243
Introduction
1243
Definition of Dehydration
1243
Estimating Dehydration
1243
Total Body Water
1244
Mechanism of Thirst
1245
Rehydration
1245
Conclusion
1247
References
1247
172 Maintenance Fluid Therapy
1249
Introduction
1249
Estimation of a Patient’s “Maintenance” Fluid Requirement
1249
Composition of a Maintenance Fluid
1250
Use of Maintenance Fluids
1250
Conclusion
1251
References
1251
173 Potassium Supplementation
1253
Introduction
1253
Potassium Physiology
1253
Causes of Hypokalemia
1253
Clinical Signs of Hypokalemia
1254
Potassium Supplementation
1254
Diabetic Ketoacidosis (see Chapter 113)
1255
References
1256
174 Administration of Sodium Bicarbonate
1257
Introduction
1257
Metabolic Acidosis (see Chapter 107)
1258
Is Acidosis Harmful?
1258
Uremic Acidosis
1258
Diabetic Ketoacidosis (see Chapter 113)
1258
Lactic Acidosis (see Chapter 156)
1259
Cardiopulmonary Cerebral Resuscitation (see Chapter 150)
1259
Hyperkalemia (see Chapter 109)
1260
Dosage and Administration
1260
References
1261
175 Continuous-Rate Infusion
1264
Preparing Drug Solutions for Infusions
1264
Fluid Bag Delivery
1264
Drug Infusions Using a Burette
1265
Preparation of Drug Infusions for Bag/Burette
1265
Labeling the Drug Infusion
1265
Standardized Concentration Infusions
1266
Drug Infusions Using a Syringe Pump
1267
Acknowledgment
1267
176 Transfusion of Red Blood Cells and Plasma
1268
Transfusion Therapy
1268
Donor and Recipient Screening
1268
Cross-Matching
1269
Blood Product Administration
1269
Transfusion Reactions
1270
References
1272
177 Massive Transfusion
1273
Introduction
1273
Common Conditions Requiring Massive Transfusion
1273
Diagnosis/Prediction
1273
Pre-Resuscitation Complications/Acute Traumatic Coagulopathy
1274
Treatment
1274
Complications
1275
Electrolyte Abnormalities
1275
Hypothermia (see Chapter 148)
1276
Acid–Base Disorders (see Chapter 107)
1276
Transfusion Reactions (see Chapter 176)
1276
Prognosis
1276
References
1276
Section 6 Emergency Room Procedures
1278
178 Vascular Access
1280
Introduction
1280
Venous Access
1280
Considerations for Venous Access
1280
Approaches and Techniques for Venous Access
1281
Locations for Venous Access
1283
Intraosseous Access
1284
Considerations for Intraosseous Access
1284
Approaches and Techniques for Intraosseous Access
1284
Arterial Access
1285
References
1285
179 Intraosseous Catheters
1286
Introduction
1286
Physiology
1286
Indications
1286
Contraindications
1287
Medications
1287
Methods
1287
Possible Complications
1288
Intraosseous Catheter Care
1288
References
1288
180 Airway Management
1290
Introduction
1290
Healthy Dog or Cat
1290
Upper Airway Obstruction (see Chapters 28 and 30–32)
1290
Difficult Intubation
1291
Tracheostomy
1292
Management of the Tracheostomy Tube
1292
Pharmacological Therapy
1292
References
1293
181 Oxygen Therapy
1294
Introduction
1294
Non-Invasive Oxygen Therapy
1294
Flow-By Oxygen
1294
Face Mask
1295
Oxygen Hood
1295
Nasal Oxygen
1295
Oxygen Cage
1296
Advanced Oxygen Delivery Methods
1296
Transtracheal Oxygen Administration
1296
High-Flow Nasal Cannula
1296
Invasive Oxygen Delivery Methods
1297
Positive Pressure Ventilation
1297
Hyperbaric Oxygen
1297
Monitoring Response to Oxygen Therapy
1297
Oxygen Toxicity
1298
Conclusion
1298
References
1299
182 Sonography in the Emergency Room
1300
Terminology
1300
Abdominal Focused Assessment of Sonography for Trauma (FAST)
1300
Target-Organ Approach
1300
Abdominal Fluid Scoring System
1300
Blunt Versus Penetrating Trauma
1303
Triage or Non-Trauma Subsets: Collapsed, Weak, Hypotensive
1303
Thoracic FAST
1303
Thoracic FAST PCS and DH Views
1303
FAST DH View and CVC for Estimating Volume Status
1306
tFAST Basic Echo Views
1307
tFAST CTS Views
1307
Vet BLUE
1307
Assumptions, Strengths, and Weaknesses of Lung Ultrasound
1307
Global FAST
1308
Global FAST for Patient Monitoring
1308
Global FAST for CPR and Advanced Life Support
1309
References
1309
183 Thoracocentesis
1312
Introduction
1312
Indications
1312
Contraindications
1312
Preparation and Considerations
1312
Procedure
1313
Identify Anatomical Landmarks
1314
Complications
1314
Postprocedure Monitoring
1314
References
1315
184 Thoracostomy Tube Placement
1316
Indications for Thoracostomy Tubes
1316
Pneumothorax
1316
Pleural Effusion (see Chapter 45)
1316
Preparation for Placement
1317
Tube Types
1317
Tube Placement Techniques
1317
Trocar Tubes
1317
Wire-Guided Tube
1317
Red Rubber Catheter
1317
Thoracostomy Tube Maintenance and Care
1318
Complications
1318
References
1318
185 Pericardiocentesis
1319
Etiology and Indications for Pericardiocentesis
1319
Contraindications
1320
Sedation (see Chapter 192)
1320
Equipment
1320
Procedure
1320
Positioning
1320
Procedural Monitoring
1320
Technique
1321
Samples to Obtain and Submit
1321
Postprocedure Monitoring
1321
Complications
1322
Pearls of Wisdom
1322
References
1322
186 Abdominocentesis
1323
Introduction
1323
Indications
1323
Technique
1323
Focused Assessment with Sonography for Trauma (see Chapter 182)
1323
Preparation of the Patient
1324
Closed-Needle Abdominocentesis
1324
Open-Needle Abdominocentesis
1324
Four-Quadrant Abdominocentesis
1324
Alternative Techniques for Abdominocentesis
1324
Diagnostic Peritoneal Lavage
1325
Abdominal Fluid Analysis
1325
Paracentesis Sample
1325
Cytological Analysis
1325
Diagnostic Peritoneal Lavage Samples
1326
Conclusion
1326
References
1326
187 Urethral Catheterization (Including Urohydropulsion)
1327
Introduction
1327
Indications for Urethral Catheterization
1327
Risks of Urethral Catheterization
1328
Catheter Considerations
1328
Size
1328
Materials
1328
Foley Catheters
1328
Placement Technique
1329
Universal
1329
Male Dogs
1329
Female Dogs
1329
Male Cats (see Chapter 98)
1330
Female Cats
1330
Retrograde Urohydropropulsion
1330
Indwelling Catheter Care
1330
References
1331
188 Mechanical Ventilation in the Emergency Room
1333
Introduction
1333
Supplies Required
1333
Personnel
1333
Transport
1333
Owner Communication
1334
Respiratory Distress (Hypoxemia)
1334
Intoxications/Envenomation
1334
Post Cardiopulmonary Resuscitation
1334
Tetraparesis
1334
Ventilation
1335
Conclusion
1335
References
1335
189 Damage Control Surgery
1336
Introduction
1336
Damage Control Surgery Stage 1: Initial Laparotomy
1336
Damage Control Surgery Stage 2: ICU Resuscitation
1338
Damage Control Surgery Stage 3: Definitive Reconstruction
1338
References
1339
Section 7 Anesthesia and Analgesia for the Emergency Room Patient
1340
190 Anesthesia and Analgesia in the Emergency Room: An Overview
1342
Introduction
1342
Origins and Sequelae of Pain
1342
General Approach to the Painful Patient
1343
Treating the Painful Emergent Patient
1343
Analgesic Agents and Tranquilizers (Figure 190.1)
1343
Induction Agents (see Figure 190.1)
1345
Inhalant Anesthetics (see Figure 190.1)
1346
Conclusion
1346
References
1346
191 Anesthetic Concerns and Protocols for Common Conditions
1348
Introduction
1348
Dystocia/Cesarean Section (see Chapter 118)
1348
Anesthetic Concerns
1348
Protocols
1348
Enucleation/Proptosis
1351
Anesthetic Concerns
1351
Protocols
1351
Foreign Body (Esophageal, Gastric, Intestinal)
1351
Anesthetic Concerns
1352
Protocols
1352
Gastric Dilation-Volvulus (see Chapter 82)
1352
Anesthetic Concerns
1352
Protocols
1352
Hemoabdomen (see Chapter 84)
1353
Anesthetic Concerns
1353
Protocols
1353
Major Wounds (see Chapter 166)
1353
Anesthetic Concerns
1353
Protocols
1353
Pacemaker
1354
Anesthetic Concerns
1354
Protocols
1354
Urethral Obstruction (Canine)
1354
Anesthetic Concerns
1354
Protocols
1355
References
1355
192 Sedation for the Emergency Room Patient
1356
Introduction
1356
Healthy Dog/Cat Emergencies
1356
Dog: Fast, Non-Painful Procedure (Radiographs, Blood Draws, Small Laceration Repair)
1356
Cat: Fast, Non-Painful Procedure (Fractious Cat Exam, Radiographs, Blood Draws)
1356
Healthy Dog: Painful Procedure (e.g. Aural Hematoma, Laceration Repair, Fracture Stabilization, Closed Hip Reduction)
1356
Healthy Cat: Painful Procedure (Laceration Repair, Fracture Stabilization, Closed Hip Reduction)
1357
Rapid Sedation For Upper Airway Obstruction/Respiratory Compromise
1357
Sedation Protocols for Brachycephalic Dogs
1357
Geriatric, Debilitated, or Hemodynamically Unstable Cat or Dog Emergencies
1357
Sedation Agents
1357
Opioids
1357
Alpha-2 Agonists
1358
Acepromazine
1358
Benzodiazepines
1358
Induction Agents Used for Sedation
1359
Propofol
1359
Alfaxalone
1359
Ketamine
1359
References
1359
193 Pain Management in Critical Patients
1362
Pain in the Emergency Patient: Concerns and Goals
1362
How Much Pain and How to Approach It
1362
Drug Interactions
1362
Dose Titration, Timing, and Duration
1363
Breakthrough and Unexpected Pain
1363
Pharmacological Methods for Treating Acute Pain
1363
Opioids
1363
NSAIDs
1364
Local Anesthetics
1364
Ketamine
1364
Dexmedetomidine
1364
Gabapentin
1365
Cryotherapy
1365
References
1365
194 Opioids
1367
Introduction
1367
Mechanism of Action
1367
Duration of Action and Administration Techniques
1368
Intravenous and Epidural Administration Techniques
1368
Alternative Routes of Administration
1369
Advantages and Side-Effects
1369
Respiratory Effects
1369
Antitussive Effects
1370
Effects on Body Temperature
1370
Opioid-Induced Hyperalgesia (OIH)
1370
Urine Retention
1370
Other Effects
1370
Patient Management Recommendations
1371
References
1371
195 Alpha-2 Adrenergic Agonists
1372
Introduction
1372
References
1374
196 Non-Steroidal Anti-Inflammatory Drugs
1375
Introduction
1375
Mechanisms of Action
1375
Pharmacokinetics
1376
Adverse Effects
1376
Hemostatic Function
1376
Gastrointestinal Effects
1376
Renal Effects
1376
Hepatic Effects
1377
Drug–Drug Interactions
1377
Clinical Usage
1377
References
1378
197 Regional Anesthesia Techniques
1380
Introduction
1380
Selected Regional Anesthetic Techniques
1380
Intercostal Nerve Blocks
1380
Interpleural Block
1380
Epidural Anesthesia
1382
Potential Complications
1383
Systemic Toxicity
1383
Nerve Injury
1383
Infection
1384
References
1384
198 Go Home Analgesics
1386
Pain Assessment
1386
Pathophysiology of Pain
1386
Go Home Analgesics
1387
Opioids
1387
Non-Steroidal Anti-Inflammatory Drugs
1387
Grapiprant
1389
Adjunctive or Alternative Analgesics
1389
Tramadol
1389
Amantadine
1389
Gabapentin
1389
Tricyclic Antidepressants
1390
Lidocaine Patches
1390
References
1390
199 Approach to the Aggressive or Fearful Emergency Room Patient
1393
Introduction
1393
Patient Fear and Aggression
1393
Recognizing Fear and Aggression in Dogs and Cats
1393
Techniques for Patient Handling and Physical Restraint
1394
Client Communication
1394
Approaching the Patient
1394
Muzzles
1394
Other Manual Restraint Tools
1395
Pharmacologic Restraint of the Aggressive or Fearful Patient
1395
Delivery of Pharmacological Agents for Restraint
1395
Pharmacological Agents for Use in Aggressive Animals
1395
References
1398
Section 8 Unique Emergency Medicine Topics
1400
200 Antimicrobial Therapy in the Emergency Patient
1402
Introduction
1402
General Considerations for Antimicrobial Selection
1402
Approach to Antimicrobial Selection for Patients with Sepsis
1403
Obtaining a Culture
1403
Timing of Antimicrobial Administration
1404
Empiric Antimicrobial Selection (Escalation Versus De-Escalation Therapy)
1404
Pharmacokinetic and Pharmacodynamic Considerations
1405
Duration of Antimicrobial Administration
1406
Source Control
1406
Conclusion
1406
References
1406
201 Disaster Medicine
1409
What is a Disaster?
1409
The Human–Animal Bond During a Disaster
1409
Organizational Structure
1410
Veterinary Disaster Response Programs
1411
Phases of Disaster Management
1411
Mitigation
1411
Preparedness
1411
Response
1412
Recovery
1413
Conclusion
1413
References
1413
202 Working Dogs in the Emergency Room
1415
Occupations
1415
Police/Patrol/Military
1415
Odor Detection
1415
Assistance/Service
1415
Occupational Hazards
1416
Common Conditions
1416
Common Systems Affected
1417
Client Education
1418
References
1419
203 Approach to Unowned and Shelter/Rescue Animals in the Emergency Room
1420
Introduction
1420
References
1422
204 Euthanasia Considerations
1423
Introduction
1423
Emotional Aspects of Euthanasia in the Emergency Setting
1423
Rapport
1423
Goals of Care Discussions in the Emergency Setting
1423
Beliefs Regarding Aid in Dying
1423
Technical Aspects of Euthanasia in the Emergency Setting
1425
Procedural Considerations: Pharmacology and Technique
1425
Procedural Considerations: Treatment Area and Patient Preparation
1425
Procedural Considerations: Client Visiting with Deceased Patients
1427
Current Concepts in Veterinary End-of-Life Care
1427
Veterinary–Social Work Partnerships
1427
Veterinary Hospice and Palliative Care
1427
Client Request for Home Death
1427
Conclusion
1427
References
1428
205 Emergency Room Design and Staffing Models
1430
Introduction
1430
General Design Concepts
1430
Goals
1430
Limitations
1430
Practical Design
1431
Entrance
1431
Reception
1431
Waiting Room
1431
Exam Rooms
1431
Visitation, Consulting, and Grieving Rooms
1432
Emergency Room
1432
Other Hospital Space
1433
Nurses’ Workstation
1434
Doctors’ Workstation
1434
Intensive Care
1434
Radiology
1434
Laboratory
1434
Care Co-ordinator Workstation
1434
Surgery
1434
Isolation
1434
Advanced Imaging (CT and MRI)
1434
Other Design Considerations for the Emergency Room
1434
Flooring
1434
Lighting
1435
Plumbing
1435
Heating, Ventilation, and Cooling
1435
Electrical System
1435
Security
1435
Cart Systems
1435
Medical Gases
1436
Cages and Runs
1436
Design Summary
1436
Staffing the Emergency Room
1436
206 Conflict in the Emergency Room
1439
Introduction
1439
Interpersonal Conflict
1439
Enhancing Constructive Conflict
1441
Conclusion
1443
References
1443
207 Maximizing Communication
1444
Core Communication Skills
1444
Open-Ended Questions
1444
Reflective Listening
1444
Empathy
1445
Non-Verbal Aspects
1445
Breaking the News/Presenting the Diagnosis
1445
Offering Options
1446
Specific Pointers
1446
Conclusion
1446
References
1446
208 Basics of Clinical Study Design
1448
Introduction
1448
The Research Question
1448
Choosing the Appropriate Subjects
1448
Planning and Recording the Measurements
1449
Choosing the Study Design
1449
Case Report
1449
Case Series
1450
Analysis of Secular Trends
1450
Case Control Study
1450
Cohort Study
1450
Experimental Study or Randomized Control Trial
1450
Retrospective Versus Prospective Studies
1450
Analysis
1450
Presenting the Results
1451
Further Reading
1451
209 Designing and Participating in Clinical Trials
1452
Clinical Trial Design
1452
Controlled Clinical Trial Design
1452
Defining the Study Population
1452
Defining the Control Group
1452
Assignment to Intervention Versus Control Groups
1452
Blinding and Outcome Assessment
1454
Placebo Effects
1454
Sample Size Considerations
1454
Statistical Analysis
1454
Clinical Trial Implementation
1455
Recruitment
1455
Data Collection
1456
Good Clinical Practice
1456
References
1456
Index
1457
EULA
1513